Healthpeak Properties, INC

Healthpeak Properties, Inc. reports strong stockholder support for its Board of Directors, executive compensation, and auditor ratification at its 2026 Annual Meeting.

Healthpeak Properties, Inc. secures a new $400 million delayed draw term loan and expands its existing term loan capacity to $2 billion, enhancing financial flexibility following the Janus IPO.

Healthpeak Properties, Inc. announced its CEO, Scott Brinker, will present at the Citi 2026 Global Property CEO Conference on March 3, 2026.

Healthpeak Properties reported fourth quarter and full-year 2025 financial results, alongside strategic updates including a planned senior housing REIT IPO and significant capital recycling initiatives.

Healthpeak Properties reported third-quarter 2025 results, highlighting strong outpatient medical and CCRC performance, strategic asset sales, and an anticipated inflection point in the biopharma sector, despite a revised full-year earnings per share outlook.

Healthpeak OP, a subsidiary of Healthpeak Properties, Inc., successfully completed an underwritten offering of $500 million in 4.750% senior notes due 2033, generating approximately $491.4 million in net proceeds for debt repayment and general corporate purposes.

Healthpeak Properties reports increased net income driven by real estate gains, but FFO declines amidst strategic investments and operational costs.

Healthpeak Properties, Inc. reported a net loss of $117.3 million for Q3 2025, primarily due to significant impairment charges in its lab joint ventures, despite revenue growth.

Healthpeak Properties, Inc. reported a significant decline in GAAP net income for Q2 2025 and the first half of 2025 due to fewer asset sales and non-recurring gains in the prior year, while core operational metrics like FFO as Adjusted and AFFO showed growth driven by merger synergies and CCRC performance.

Healthpeak Properties reports a significant increase in net income attributable to Healthpeak Properties, Inc. for Q1 2025, driven by merger synergies and portfolio growth.

Healthpeak Properties' Q3 2024 results reflect the impact of its merger with Physicians Realty Trust, strategic asset sales, and ongoing development activities.

Healthpeak Properties reports a significant increase in net income and revenue for the second quarter of 2024, driven by the recent merger with Physicians Realty Trust and strategic asset dispositions.

Healthpeak Properties' 2024 10-K filing highlights the completion of the Physicians Realty Trust merger, strategic portfolio adjustments, and a focus on healthcare real estate.

Healthpeak Properties, Inc. outlines its capital structure, ownership restrictions, and corporate governance policies in its annual 10-K filing.

Director John T. Thomas acquired 1,385 shares of Healthpeak Properties, Inc. through the company's Employee Stock Purchase Plan.

EVP and Treasurer Ankit B. Patadia acquired 1,358 shares of Healthpeak Properties common stock via the company's Employee Stock Purchase Plan.

Healthpeak Properties CFO Kelvin Moses acquired 937 shares of common stock through the company's Employee Stock Purchase Plan.

Chief Investment Officer Adam G. Mabry acquired 625 shares of Healthpeak Properties common stock through the company's Employee Stock Purchase Plan.

EVP and CAO Shawn G. Johnston acquired 1,358 shares of Healthpeak Properties common stock via the company's Employee Stock Purchase Plan.

Healthpeak Properties CEO Scott Brinker acquired 1,347 shares through the company's Employee Stock Purchase Plan.

Healthpeak Properties, Inc. reports solid 2025 financial and operational performance, including a 4% same-store NOI growth, and announces the planned IPO of its senior housing portfolio as Janus Living, Inc.

Healthpeak Properties, Inc. announces its 2025 Annual Meeting of Stockholders, detailing proposals for director elections, executive compensation, and other key items.

Healthpeak Properties' proxy statement highlights the company's strategic focus on healthcare real estate and strong operational results in 2024 following its merger with Physicians Realty Trust.

Healthpeak Properties, Inc. announces its 2024 Annual Meeting of Stockholders to be held on April 25, 2024, detailing proposals for director elections, executive compensation approval, and auditor ratification.

Healthpeak Properties' proxy statement details the company's strategy, governance practices, and executive compensation for the upcoming annual meeting.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 4.3% of Healthpeak Properties, Inc. common stock as of June 30, 2026.

Healthpeak Properties, Inc. and its subsidiary Janus Member, LLC have reported beneficial ownership of 81.6% of Janus Living, Inc.'s Class A-1 Common Stock as of March 31, 2026.

JPMorgan Chase & Co. has reported beneficial ownership of 6.1% of Healthpeak Properties, Inc. common stock as of March 31, 2026.

Vanguard Capital Management reports beneficial ownership of 51,643,591 shares, representing 7.42% of Healthpeak Properties Inc.'s common stock as of March 31, 2026.

Vanguard Portfolio Management reports beneficial ownership of 8.37% of Healthpeak Properties' common stock as of March 31, 2026.

The Vanguard Group has reported zero beneficial ownership in Healthpeak Properties Inc. following an internal corporate realignment.